Carrier-free nanoprodrug for p53-mutated tumor therapy via concurrent delivery of zinc-manganese dual ions and ROS.
Bioact Mater
; 20: 404-417, 2023 Feb.
Article
de En
| MEDLINE
| ID: mdl-35784636
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Langue:
En
Journal:
Bioact Mater
Année:
2023
Type de document:
Article